Drug company wants partner to divest itself of recently acquired competitor

A Colombian pharmaceutical company accuses its U.S. partner in Miami federal court of forcing it into an antitrust situation with its recent purchase of a European competitor.

This article requires premium access

This article requires premium access to Daily Business Review. Please sign in or subscribe to read the full text.